RNAM
insider transactionsAvidity Biosciences, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-58.4K
0 buy · 58.4K sell
Net value · 365d
-$4.2M
$0 in · $4.2M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
18
0 buy · 58.4K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·D
Chief Human Resources Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
78.0K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
54.0K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
108.0K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
57.5K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
65.0K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
106.0K sh
Own -100%
-
Other·D
Chief Human Resources Officer
—
165.3K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -100%
-
Other·D
Chief Financial Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Financial Officer
—
106.0K sh
Own -100%
-
Other·D
Chief Financial Officer
—
60.1K sh
Own -100%
-
Other·D
Chief Financial Officer
—
148.0K sh
Own -100%
-
Other·D
Chief Financial Officer
—
131.2K sh
Own -100%
-
Other·D
Chief Financial Officer
—
92.0K sh
Own -100%
-
Other·D
Chief Financial Officer
—
134.0K sh
Own -100%
-
Other·D
Director
—
42.3K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -100%
-
Other·D
Chief Medical Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Medical Officer
—
68.5K sh
Own -100%
-
Other·D
Chief Medical Officer
—
49.3K sh
Own -100%
-
Other·D
Chief Medical Officer
—
74.0K sh
Own -100%
-
Other·D
Chief Medical Officer
—
73.3K sh
Own -100%
-
Other·D
Chief Medical Officer
—
115.9K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
165.0K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
200.0K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
400.0K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
425.0K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
300.0K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
386.0K sh
Own -100%
-
Other·D
Sarah Boyce KEY
President and CEO
—
474.9K sh
Own -100%
-
Other·D
Chief Legal Officer
—
160.0K sh
Own -100%
-
Other·D
Chief Legal Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Legal Officer
—
92.1K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
88.0K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
72.0K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
96.0K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
66.5K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
25.0K sh
Own -100%
-
Other·D
Chief Scientific Officer
—
150.4K sh
Own -100%
-
Other·D
Director
—
15.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
13.7K sh
Own -100%
-
Other·D
Director
—
65.1K sh
Own -100%
-
Other·D
Chief Program Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Program Officer
—
16.0K sh
Own -100%
-
Other·D
Chief Program Officer
—
13.5K sh
Own -100%
-
Other·D
Chief Program Officer
—
42.5K sh
Own -100%
-
Other·D
Chief Program Officer
—
27.6K sh
Own -100%
-
Other·D
Chief Program Officer
—
13.4K sh
Own -100%
-
Other·D
Chief Program Officer
—
9.2K sh
Own -100%
-
Other·D
Chief Program Officer
—
13.8K sh
Own -100%
-
Other·D
Chief Program Officer
—
22.3K sh
Own -100%
-
Other·D
Chief Program Officer
—
80.3K sh
Own -100%
-
Other·D
Director
—
9.5K sh
Own -100%
-
Other·D
Director
—
11.3K sh
Own -100%
-
Other·D
Director
—
15.0K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -100%
-
Other·D
Director
—
30.0K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -100%
-
Other·D
Director
—
12.5K sh
Own -100%
-
Other·D
Director
—
115.5K sh
Own -100%
-
Other·D
Director
—
144.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
131.4K sh
Own -100%
-
Other·D
Director
—
16.6K sh
Own -100%
-
Other·D
Director
—
9.5K sh
Own -100%
-
Other·D
Director
—
11.3K sh
Own -100%
-
Other·D
Director
—
15.0K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -100%
-
Other·D
Director
—
20.9K sh
Own -100%
-
Other·D
Director
—
15.0K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
13.5K sh
Own -100%
-
Other·D
Director
—
10.0K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
50.0K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
177.2K sh
Own -100%
-
Other·D
Chief Commercial Officer
—
79.4K sh
Own -100%
-
Other·D
Chief Technical Officer
—
80.0K sh
Own -100%
-
Other·D
Chief Technical Officer
—
98.5K sh
Own -100%
-
Sell·S
Chief Medical Officer · 10b5-1
$208.5K
2.9K sh · $72.45
Own -8%
-
Sell·S
Chief Medical Officer · 10b5-1
$146.1K
2.0K sh · $72.45
Own -6%
-
Sell·S
Sarah Boyce KEY
President and CEO · 10b5-1
$579.1K
8.0K sh · $72.45
Own -3%
-
Sell·S
Sarah Boyce KEY
President and CEO · 10b5-1
$463.2K
6.4K sh · $72.45
Own -2%
-
Sell·S
Chief Scientific Officer · 10b5-1
$185.3K
2.6K sh · $72.45
Own -3%
-
Sell·S
Chief Scientific Officer · 10b5-1
$288.1K
4.0K sh · $72.45
Own -4%
-
Sell·S
Chief Financial Officer · 10b5-1
$198.2K
2.7K sh · $72.45
Own -4%
-
Sell·S
Chief Financial Officer · 10b5-1
$130.9K
1.8K sh · $72.45
Own -3%
-
Sell·S
Director · 10b5-1
$127.4K
1.8K sh · $72.45
Own -10%
-
Sell·S
Chief Human Resources Officer · 10b5-1
$105.3K
1.5K sh · $72.45
Own -1%
-
Sell·S
Chief Human Resources Officer · 10b5-1
$106.9K
1.5K sh · $72.45
Own -1%
-
Sell·S
Sarah Boyce KEY
President and CEO · 10b5-1
$619.4K
8.6K sh · $72.23
Own -3%
-
Sell·S
Chief Technical Officer · 10b5-1
$269.2K
3.7K sh · $72.23
Own -7%
-
Sell·S
Chief Human Resources Officer · 10b5-1
$141.9K
2.0K sh · $72.23
Own -2%
-
Sell·S
Chief Legal Officer · 10b5-1
$171.5K
2.4K sh · $72.23
Own -3%
-
Sell·S
Chief Financial Officer · 10b5-1
$142.6K
2.0K sh · $72.23
Own -3%
-
Sell·S
Chief Medical Officer · 10b5-1
$171.4K
2.4K sh · $72.23
Own -6%
-
Sell·S
Chief Scientific Officer · 10b5-1
$171.4K
2.4K sh · $72.23
Own -3%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Teresa Mccarthy | Other D | 50.0K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 78.0K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 54.0K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 108.0K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 57.5K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 65.0K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 106.0K | — |
| Feb 27, 2026 | Teresa Mccarthy | Other D | 165.3K | — |
| Feb 27, 2026 | Tamar Thompson | Other D | 22.0K | — |
| Feb 27, 2026 | Tamar Thompson | Other D | 13.5K | — |
| Feb 27, 2026 | Tamar Thompson | Other D | 10.0K | — |
| Feb 27, 2026 | Tamar Thompson | Other D | 6.7K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 50.0K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 106.0K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 60.1K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 148.0K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 131.2K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 92.0K | — |
| Feb 27, 2026 | Michael F Maclean KEY | Other D | 134.0K | — |
| Feb 27, 2026 | Simona Skerjanec | Other D | 42.3K | — |
| Feb 27, 2026 | Simona Skerjanec | Other D | 10.0K | — |
| Feb 27, 2026 | Simona Skerjanec | Other D | 6.7K | — |
| Feb 27, 2026 | Steven George Hughes | Other D | 50.0K | — |
| Feb 27, 2026 | Steven George Hughes | Other D | 68.5K | — |
| Feb 27, 2026 | Steven George Hughes | Other D | 49.3K | — |
| Feb 27, 2026 | Steven George Hughes | Other D | 74.0K | — |
| Feb 27, 2026 | Steven George Hughes | Other D | 73.3K | — |
| Feb 27, 2026 | Steven George Hughes | Other D | 115.9K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 165.0K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 200.0K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 400.0K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 425.0K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 300.0K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 386.0K | — |
| Feb 27, 2026 | Sarah Boyce KEY | Other D | 474.9K | — |
| Feb 27, 2026 | John B Moriarty | Other D | 160.0K | — |
| Feb 27, 2026 | John B Moriarty | Other D | 50.0K | — |
| Feb 27, 2026 | John B Moriarty | Other D | 92.1K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 50.0K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 88.0K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 72.0K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 96.0K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 66.5K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 25.0K | — |
| Feb 27, 2026 | Michael W. Flanagan | Other D | 150.4K | — |
| Feb 27, 2026 | Troy Edward Wilson | Other D | 15.0K | — |
| Feb 27, 2026 | Troy Edward Wilson | Other D | 13.5K | — |
| Feb 27, 2026 | Troy Edward Wilson | Other D | 10.0K | — |
| Feb 27, 2026 | Troy Edward Wilson | Other D | 13.7K | — |
| Feb 27, 2026 | Troy Edward Wilson | Other D | 65.1K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 50.0K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 16.0K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 13.5K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 42.5K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 27.6K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 13.4K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 9.2K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 13.8K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 22.3K | — |
| Feb 27, 2026 | Kathleen P. Gallagher | Other D | 80.3K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 9.5K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 11.3K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 15.0K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 22.0K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 13.5K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 10.0K | — |
| Feb 27, 2026 | Noreen Henig | Other D | 6.7K | — |
| Feb 27, 2026 | Jean Jinsun Kim | Other D | 30.0K | — |
| Feb 27, 2026 | Jean Jinsun Kim | Other D | 22.0K | — |
| Feb 27, 2026 | Jean Jinsun Kim | Other D | 13.5K | — |
| Feb 27, 2026 | Jean Jinsun Kim | Other D | 10.0K | — |
| Feb 27, 2026 | Jean Jinsun Kim | Other D | 6.7K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 12.5K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 115.5K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 144.0K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 13.5K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 10.0K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 131.4K | — |
| Feb 27, 2026 | LEVIN ARTHUR A | Other D | 16.6K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 9.5K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 11.3K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 15.0K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 22.0K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 13.5K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 10.0K | — |
| Feb 27, 2026 | Edward M. Kaye MD | Other D | 6.7K | — |
| Feb 27, 2026 | Carsten Boess | Other D | 20.9K | — |
| Feb 27, 2026 | Carsten Boess | Other D | 15.0K | — |
| Feb 27, 2026 | Carsten Boess | Other D | 22.0K | — |
| Feb 27, 2026 | Carsten Boess | Other D | 13.5K | — |
| Feb 27, 2026 | Carsten Boess | Other D | 10.0K | — |
| Feb 27, 2026 | Carsten Boess | Other D | 6.7K | — |
| Feb 27, 2026 | Eric Mosbrooker | Other D | 50.0K | — |
| Feb 27, 2026 | Eric Mosbrooker | Other D | 177.2K | — |
| Feb 27, 2026 | Eric Mosbrooker | Other D | 79.4K | — |
| Feb 27, 2026 | Charles Calderaro III | Other D | 80.0K | — |
| Feb 27, 2026 | Charles Calderaro III | Other D | 98.5K | — |
| Jan 21, 2026 | Steven George Hughes 10b5-1 | Sell S | 2.9K | $208.5K |
| Jan 21, 2026 | Steven George Hughes 10b5-1 | Sell S | 2.0K | $146.1K |
| Jan 21, 2026 | Sarah Boyce KEY 10b5-1 | Sell S | 8.0K | $579.1K |
| Jan 21, 2026 | Sarah Boyce KEY 10b5-1 | Sell S | 6.4K | $463.2K |
| Jan 21, 2026 | Michael W. Flanagan 10b5-1 | Sell S | 2.6K | $185.3K |
| Jan 21, 2026 | Michael W. Flanagan 10b5-1 | Sell S | 4.0K | $288.1K |
| Jan 21, 2026 | Michael F Maclean KEY 10b5-1 | Sell S | 2.7K | $198.2K |
| Jan 21, 2026 | Michael F Maclean KEY 10b5-1 | Sell S | 1.8K | $130.9K |
| Jan 21, 2026 | LEVIN ARTHUR A 10b5-1 | Sell S | 1.8K | $127.4K |
| Jan 21, 2026 | Teresa Mccarthy 10b5-1 | Sell S | 1.5K | $105.3K |
| Jan 21, 2026 | Teresa Mccarthy 10b5-1 | Sell S | 1.5K | $106.9K |
| Jan 7, 2026 | Sarah Boyce KEY 10b5-1 | Sell S | 8.6K | $619.4K |
| Jan 7, 2026 | Charles Calderaro III 10b5-1 | Sell S | 3.7K | $269.2K |
| Jan 7, 2026 | Teresa Mccarthy 10b5-1 | Sell S | 2.0K | $141.9K |
| Jan 7, 2026 | John B Moriarty 10b5-1 | Sell S | 2.4K | $171.5K |
| Jan 7, 2026 | Michael F Maclean KEY 10b5-1 | Sell S | 2.0K | $142.6K |
| Jan 7, 2026 | Steven George Hughes 10b5-1 | Sell S | 2.4K | $171.4K |
| Jan 7, 2026 | Michael W. Flanagan 10b5-1 | Sell S | 2.4K | $171.4K |
About RNAM insider trading
This page tracks insider transactions for Avidity Biosciences, Inc. (RNAM) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.